Diligence memo · auto-generated · as of July 2, 2026

Corami Biotech Inc.

Corami Biotech Inc. has raised $210K over 2 rounds; too few niche peers to rank its valuation yet.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Corami Biotech Inc. operates in Biotech, based in MEMPHIS.

Sub-sector tags: biotech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Corami Biotech Inc. has raised $210K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $110K on 2024-10-24.

Most recent recorded round closed around 2025-01-17.

Valuation (modeled)modeled

Provath models Corami Biotech Inc. at approximately $329K (range $53K–$937K). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Historic cadence: a new round about every 3 months.

Last raise 17 mo ago; this sector typically re-raises about every 11 months.

Slightly overdue versus sector cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 69% of Biotech peers (233 compared).

Modeled value ranks above 67% of those peers.

Closest niche peers: Upstream Biotechnology, Inc., Epoch Biotech, LLC.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.